A novel cancer immunotherapy utilizing autologous tumour tissue.
Haemin ParkMatthew GladstoneCrystal ShanleyRaymond P GoodrichAmanda GuthPublished in: Vox sanguinis (2020)
These data suggest that the RF + UV inactivation of tumour cells may provide an efficacious method for generating autologous whole tumour cell vaccines for use in cancer patients.